Christopher Gibson Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

Christopher Gibson Transaction History

Date	Transaction	Value	Shares Traded
Apr 21 2022	SELL Open market or private sale	$15,450 $6.18 p/Share	2,500
Apr 21 2022	BUY Conversion of derivative security	-	2,500
Apr 18 2022	SELL Open market or private sale	$16,775 $6.71 p/Share	2,500
Apr 18 2022	BUY Conversion of derivative security	-	2,500
Apr 14 2022	SELL Open market or private sale	$18,775 $7.51 p/Share	2,500
Apr 14 2022	BUY Conversion of derivative security	-	2,500
Apr 08 2022	SELL Open market or private sale	$16,750 $6.7 p/Share	2,500
Apr 08 2022	BUY Conversion of derivative security	-	2,500
Apr 07 2022	SELL Open market or private sale	$16,275 $6.51 p/Share	2,500
Apr 07 2022	BUY Conversion of derivative security	-	2,500
Apr 06 2022	SELL Open market or private sale	$16,400 $6.56 p/Share	2,500
Apr 06 2022	BUY Conversion of derivative security	-	2,500
Apr 05 2022	SELL Open market or private sale	$18,300 $7.32 p/Share	2,500
Apr 05 2022	BUY Conversion of derivative security	-	2,500
Dec 07 2021	SELL Open market or private sale	$64,938 $20.78 p/Share	3,125
Nov 21 2021	BUY Bona fide gift	-	1,100,000
Apr 20 2021	SELL Other acquisition or disposition	-	150,000
Apr 20 2021	BUY Other acquisition or disposition	-	150,000

Chief Executive Officer

Salt Lake City, UT

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Value

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

Operation

Value

Type

Receive news related to RECURSION PHARMACEUTICALS, INC.